UM  > Institute of Chinese Medical Sciences
Residential Collegefalse
Status已發表Published
Recent advances in the biosynthesis, structure-activity relationships, formulations, pharmacology, and clinical trials of fisetin
Zhong, Ruting1; Mohamed, Farag2; Chen, Meiwan1; He, Chengwei1; Xiao, Jianbo3
2022-05
Source PublicationGoogle scholar
ISSN2666-3066
Volume3Issue:1-2
Abstract

Fisetin is one of the most popular flavonoids found in vegetables and fruits with several health benefits such as antidiabetic, anticancer, and anti-inflammatory activities. Biotechnology or chemosynthesis tools were used for the synthesis of fisetin and its analogs to improve their yield and efficacy. Structure activity relationships (SARs) revealed that the aromatic hydroxyl groups especially the 3,4-dihydroxylation at ring B were crucial for fisetin biological activities, whereas substitution of several hydroxyl groups in fisetin appeared to impact its original effects. The ongoing or upcoming clinical trials containing fisetin are applied in drugs and dietary supplements. Noteworthily, fisetin has been successfully incorporated into nutraceuticals in the market. Furthermore, the delivery system of fisetin-loaded nanocochleates showed the best bioavailability compared to other formulations. This review presents the latest research progress of fisetin on its synthesis, structure–activity relationships, pharmacokinetics, biological activities, and underlying mechanisms, bioavailability, delivery systems, and clinical trials to provide a comprehensive insight into the research and application of this valuable natural compound.

KeywordBioactivities Bioavailability Clinical Trials Fistein Formulation Molecular Mechanism Pharmacokinetics, Structure–activity Relationship
DOI10.1002/efd2.3
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorMohamed, Farag; Chen, Meiwan; He, Chengwei; Xiao, Jianbo
Affiliation1.Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macau, China
2.Pharmacognosy Department, College of Pharmacy, Cairo University, Cairo, Egypt
3.Department of Analytical and Food Chemistry, Faculty of Sciences, Universidade de Vigo, Ourense, Spain
First Author AffilicationInstitute of Chinese Medical Sciences
Corresponding Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Zhong, Ruting,Mohamed, Farag,Chen, Meiwan,et al. Recent advances in the biosynthesis, structure-activity relationships, formulations, pharmacology, and clinical trials of fisetin[J]. Google scholar, 2022, 3(1-2).
APA Zhong, Ruting., Mohamed, Farag., Chen, Meiwan., He, Chengwei., & Xiao, Jianbo (2022). Recent advances in the biosynthesis, structure-activity relationships, formulations, pharmacology, and clinical trials of fisetin. Google scholar, 3(1-2).
MLA Zhong, Ruting,et al."Recent advances in the biosynthesis, structure-activity relationships, formulations, pharmacology, and clinical trials of fisetin".Google scholar 3.1-2(2022).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhong, Ruting]'s Articles
[Mohamed, Farag]'s Articles
[Chen, Meiwan]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhong, Ruting]'s Articles
[Mohamed, Farag]'s Articles
[Chen, Meiwan]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhong, Ruting]'s Articles
[Mohamed, Farag]'s Articles
[Chen, Meiwan]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.